Services of MTRC

Meet MTRC’s Director, Dr. Oleg Borisenko, at the Pharma 4.0 - Digital Healthcare Conference in Berlin. Visit us at Booth #9 to explore tailored solutions in market access, health economics, and evidence synthesis for complex MedTech challenges. Don’t miss Dr. Borisenko’s expert talk on the reimbursement of digital technologies in Europe on 22 May at 10:50 AM.

MTRC is pleased to announce the release of its latest White Paper: "Case study: Market Access Pathway for Preeclampsia Predictive Tests in Germany and Norway". This document provides a detailed case study on how developers of IVD tests can effectively navigate reimbursement pathways in key European markets using the examples of pathways in Germany and Norway.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better. From the week of the 5th of May, we plan to work on 19 projects. Review the complete list of planned activities in this post.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better. From the week of the 21st of April, we plan to work on 19 projects. Review the complete list of planned activities in this post.

MTRC is pleased to announce the release of its latest White Paper: "Reimbursement and HTA - Things You Might Be Missing". This document highlights the challenges market access professionals face in staying current with reimbursement and HTA developments and examines how the MTRC Market Access Monitor can help bridge these gaps.

MTRC is pleased to announce the release of its latest White Paper: "Case study: Market Access Pathway for TAVI in France". This document provides a detailed case study on how developers of medical technology (specifically - implants) can successfully navigate reimbursement pathways in key European markets, focusing on France.

MTRC is pleased to announce the release of its latest White Paper: "Reimbursement Pathways for Companion Diagnostic (CDx) Tests in Europe". This document provides a comprehensive overview of the reimbursement landscape for CDx tests in five largest European countries: England, France, Germany, Italy, and Spain.

MTRC is pleased to announce the release of its latest White Paper: "Challenges of HTA and Reimbursement Submissions for Medical Devices". This White Paper explores key challenges in reimbursement and HTA submission processes for medical devices and proposes practical solutions to address them.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better. From the week of the 07th of April, we plan to work on 21 projects. Review the complete list of planned activities in this post.

MTRC is pleased to announce the release of its latest White Paper: "Challenges of Health Economic Evaluations of In-Vitro Diagnostic Tests". This white paper examines the unique challenges involved in conducting health economic evaluations of IVD tests and outlines practical best practices.

MTRC is pleased to announce the release of its latest White Paper: "Innovative Payment Schemes for Medical Devices". White Paper offers a summary of innovative payment schemes for medical devices that permit direct applications by the Med Tech industry, including the Innovative Devices Access Pathway (IDAP) in the UK, Forfait Innovation and Article 51 in France, and co-funded clinical studies under §137e in Germany.

MTRC is pleased to announce the release of its latest White Paper: "Challenges and Proposed Solutions in Systematic Literature Reviews for Medical Devices." This White Paper addresses challenges such as limited high-quality studies, variability in clinical outcomes due to operator experience, and evolving device generations. By addressing these critical challenges, MTRC empowers stakeholders in the medical technology sector to navigate the complexities of evidence assessment confidently.